Leaderboards/genetic and kidney cyst diseases

genetic and kidney cyst diseases

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Izabela Zakrocka
Medical University of Lublin
90
2
Cheng Xue
Second Military Medical University
80
3
Xiaolong Gao
University of Missouri
70
4
Tzyh‐Chang Hwang
National Yang Ming Chiao Tung University
60
5
Alastair D. Smith
Duke Medical Center
60
6
Jiayi Lv
Second Military Medical University
50
7
Xiaogang Li
Mayo Clinic
40
8
Zhiguo Mao
Second Military Medical University
10

Rising Stars Papers

1
CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease
Cells|2024
13 cit.
2
STING Promotes the Progression of ADPKD by Regulating Mitochondrial Function, Inflammation, Fibrosis, and Apoptosis
Biomolecules|2024
9 cit.
3
Downregulation of <scp>EZH2</scp> Promotes Renal Epithelial Cellular Senescence and Kidney Aging
The FASEB Journal|2025
4 cit.
4
P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism
Cell Death Discovery|2025
4 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Courtney E. Vishy
University of Washington
99
2
Elizabeth P. Henske
Brigham and Women's Hospital
90
3
Whitney S. Thompson
Mayo Clinic
80
4
Laura R. Claus
University Medical Center Utrecht
70
5
Cuiting Peng
Sichuan University
60
6
Chiara Dordoni
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
50
7
Scott H. Waddell
Institute of Genetics and Cancer
40
8
Teresa Bada-Bosch
Hospital Universitario 12 De Octubre
30
9
Yi Huang
University of Southern California
20
10
Tabinda Jawaid
Mayo Clinic
20

Emerging Leaders Papers

1
mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
Nature Communications|2023
111 cit.
2
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
Nature Communications|2024
43 cit.
3
Oral delivery of nanomedicine for genetic kidney disease
PNAS Nexus|2024
9 cit.
4
Oral Delivery of Kidney Targeting Nanotherapeutics for Polycystic Kidney Disease
bioRxiv (Cold Spring Harbor Laboratory)|2022
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Stefan Somlo
Yale University
99
2
Roser Torrá
Universitat Autònoma de Barcelona
99
3
Gregory G. Germino
Johns Hopkins University
90
4
Alan Horwich
Institute of Cancer Research
80
5
Thomas Weimbs
University of California, Santa Barbara
70
6
Vicente E. Torres
Mayo Clinic
50
7
Peter Igarashi
Howard Hughes Medical Institute
40
8
Friedhelm Hildebrandt
University of Michigan–Ann Arbor
30
9
Peter C. Harris
Mayo Clinic
30
10
D. J. Weatherall
John Radcliffe Hospital
20

All-Time Leaders Papers

1
Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease
The American Journal of Human Genetics|2016
463 cit.
2
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Journal of Clinical Investigation|2012
444 cit.
3
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.
Journal of Clinical Investigation|1998
417 cit.
4
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Journal of Clinical Investigation|2011
398 cit.
5
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease
The American Journal of Human Genetics|2018
310 cit.
6
Mutations in SEC63 cause autosomal dominant polycystic liver disease
Nature Genetics|2004
282 cit.
7
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
British Journal of Cancer|2005
230 cit.
8
Defects in the IFT-B Component IFT172 Cause Jeune and Mainzer-Saldino Syndromes in Humans
The American Journal of Human Genetics|2013
228 cit.
9
ZMYND10 Is Mutated in Primary Ciliary Dyskinesia and Interacts with LRRC6
The American Journal of Human Genetics|2013
204 cit.
10
KANK deficiency leads to podocyte dysfunction and nephrotic syndrome
Journal of Clinical Investigation|2015
198 cit.

Reagents for genetic and kidney cyst diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Proteintech

Alpha Tubulin

Cited in 11 papers
#CL555-80762$479
View Evidence →Cell Signaling Technology

FoxP1 (D35D10) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Red 780 Conjugate)

Cited in 10 papers
#28175$458
View Evidence →Cell Signaling Technology

JIP4/SPAG9 (D72F4) Rabbit Monoclonal Antibody

Cited in 10 papers
#5519$173
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

PIAS1 (D33A7) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 14 papers
#50580$865
View Evidence →Proteintech

Alpha Tubulin

Cited in 11 papers
#CL488-80762$189
View Evidence →Proteintech

Gamma Tubulin

Cited in 11 papers
#87860-2-RR$449
View Evidence →